Activation of trans geometry in bifunctional mononuclear platinum complexes by a piperidine ligand. Mechanistic studies on antitumor action
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
12970368
DOI
10.1074/jbc.m304720200
PII: S0021-9258(20)75775-3
Knihovny.cz E-resources
- MeSH
- DNA Adducts chemistry MeSH
- Time Factors MeSH
- Models, Chemical MeSH
- CHO Cells MeSH
- Cisplatin pharmacokinetics MeSH
- DNA Polymerase I chemistry MeSH
- DNA chemistry MeSH
- HeLa Cells MeSH
- HIV Reverse Transcriptase chemistry MeSH
- Hydroxyl Radical MeSH
- Cricetinae MeSH
- Humans MeSH
- Ligands MeSH
- Molecular Sequence Data MeSH
- Oligonucleotides chemistry MeSH
- Piperidines chemistry MeSH
- Platinum chemistry MeSH
- Antineoplastic Agents pharmacology MeSH
- Cross-Linking Reagents pharmacology MeSH
- Base Sequence MeSH
- Models, Theoretical MeSH
- Dose-Response Relationship, Drug MeSH
- Animals MeSH
- Check Tag
- Cricetinae MeSH
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- DNA Adducts MeSH
- Cisplatin MeSH
- DNA Polymerase I MeSH
- DNA MeSH
- HIV Reverse Transcriptase MeSH
- Hydroxyl Radical MeSH
- Ligands MeSH
- Oligonucleotides MeSH
- piperidine MeSH Browser
- Piperidines MeSH
- Platinum MeSH
- Antineoplastic Agents MeSH
- Cross-Linking Reagents MeSH
- transplatin MeSH Browser
A paradigm for the structure-pharmacological activity relationship of bifunctional platinum antitumor drugs is that the trans isomer of antitumor cisplatin (transplatin) is clinically ineffective. To this end, however, several new complexes of the trans structure have been identified that exhibit cytotoxicity in tumor cells that is even better than that of the analogous cis isomers. We reported recently (Kasparkova, J., Marini, V., Najajreh, Y., Gibson, D., and Brabec, V. (2003) Biochemistry 42, 6321-6332) that the replacement of one ammine ligand by the heterocyclic ligand, such as piperidine, piperazine, or 4-picoline in the molecule of transplatin resulted in a radical enhancement of its cytotoxicity. We examined oligodeoxyribonucleotide duplexes bearing a site-specific cross-link of the transplatin analogue containing the piperidine ligand by biochemical methods. The results indicate that in contrast to transplatin, trans-(PtCl2(NH3)(piperidine)) forms stable 1,3-intrastrand cross-links in double-helical DNA that distort DNA and are not readily removed from DNA by nucleotide excision repair system. Hence, the intrastrand cross-links of trans-(PtCl2(NH3)(piperidine)) could persist for a sufficiently long time, potentiating its toxicity toward tumor cells. trans-(PtCl2(NH3)(piperidine)) also forms in DNA minor interstrand cross-links that are similar to those of transplatin so that these adducts appear less likely candidates for genotoxic lesion responsible for antitumor effects of trans-(PtCl2(NH3)(piperidine)). Hence, the role of structurally unique intrastrand cross-links in the anti-tumor effects of transplatin analogues in which one ammine group is replaced by a heterocyclic ligand may predominate.
References provided by Crossref.org
Mechanism of the formation of DNA-protein cross-links by antitumor cisplatin